Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bayer MaterialScience AG has invested EUR 2.3 million in a new production line for its Baycusan range of waterborne polyurethane dispersions (PUD) for the cosmetics and medical segments. The new facility, which forms part of the PUD plant at the Dormagen CHEMPARK, will produce special, top-quality polyurethane dispersions of maximum purity, which will be sold to the cosmetics industry under the name Baycusan C. The dispersions do not contain any kind of co-solvent, are free of preservatives and thus have characteristics that are unique to this market.

Today in Marketing/Media/ROI...keeping you current

Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09

Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address